149 related articles for article (PubMed ID: 36408341)
1. Knockdown of lncRNA
Chen F; Zhao RR; Li Q; Chen ZH; Luo C
Evid Based Complement Alternat Med; 2022; 2022():9337647. PubMed ID: 36408341
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA HOXD-AS2 regulates cell cycle to promote glioma progression.
Qi Y; Wang Z; Wu F; Yin B; Jiang T; Qiang B; Yuan J; Han W; Peng X
J Cell Biochem; 2019 May; 120(5):8343-8351. PubMed ID: 30485495
[TBL] [Abstract][Full Text] [Related]
3. A Positive Feedback Loop of lncRNA HOXD-AS2 and SMYD3 Facilitates Hepatocellular Carcinoma Progression via the MEK/ERK Pathway.
Sun J; Li Y; Shi M; Tian H; Li J; Zhu K; Guo Y; Mu Y; Geng J; Li Z
J Hepatocell Carcinoma; 2023; 10():1237-1256. PubMed ID: 37533602
[TBL] [Abstract][Full Text] [Related]
4. Production and Stabilization of Specific Upregulated Long Noncoding RNA HOXD-AS2 in Glioblastomas Are Mediated by TFE3 and miR-661, Respectively.
Qin Y; Qi Y; Zhang X; Guan Z; Han W; Peng X
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269968
[TBL] [Abstract][Full Text] [Related]
5. HOXD-AS2-STAT3 feedback loop attenuates sensitivity to temozolomide in glioblastoma.
Zhang ZX; Ren P; Cao YY; Wang TT; Huang GH; Li Y; Zhou S; Yang W; Yang L; Liu GL; Xiang Y; Pei YC; Chen QZ; Chen JX; Lv SQ
CNS Neurosci Ther; 2023 Nov; 29(11):3430-3445. PubMed ID: 37308741
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of the long non-coding RNA
Yao L; Ye PC; Tan W; Luo YJ; Xiang WP; Liu ZL; Fu ZM; Lu F; Tang LH; Xiao JW
World J Gastrointest Oncol; 2020 Nov; 12(11):1237-1254. PubMed ID: 33250958
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.
Zhang X; Niu W; Mu M; Hu S; Niu C
J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of lncRNA HOXD-AS1 suppresses proliferation, migration and invasion and enhances cisplatin sensitivity of glioma cells by sponging miR-204.
Zhou H; Ma Y; Zhong D; Yang L
Biomed Pharmacother; 2019 Apr; 112():108633. PubMed ID: 30784927
[TBL] [Abstract][Full Text] [Related]
9. Promoter and enhancer RNAs regulate chromatin reorganization and activation of miR-10b/HOXD locus, and neoplastic transformation in glioma.
Deforzh E; Uhlmann EJ; Das E; Galitsyna A; Arora R; Saravanan H; Rabinovsky R; Wirawan AD; Teplyuk NM; El Fatimy R; Perumalla S; Jairam A; Wei Z; Mirny L; Krichevsky AM
Mol Cell; 2022 May; 82(10):1894-1908.e5. PubMed ID: 35390275
[TBL] [Abstract][Full Text] [Related]
10. LncRNA NFIA-AS2 promotes glioma progression through modulating the miR-655-3p/ZFX axis.
Xin J; Zhao YH; Zhang XY; Tian LQ
Hum Cell; 2020 Oct; 33(4):1273-1280. PubMed ID: 32779154
[TBL] [Abstract][Full Text] [Related]
11. Silencing of lncRNA CHRM3-AS2 Expression Exerts Anti-Tumour Effects Against Glioma
Wang D; Chen Q; Liu J; Liao Y; Jiang Q
Front Oncol; 2022; 12():856381. PubMed ID: 35359381
[TBL] [Abstract][Full Text] [Related]
12. Long Non-Coding RNA HOXA-AS2 Enhances The Malignant Biological Behaviors In Glioma By Epigenetically Regulating RND3 Expression.
Wu L; Zhu X; Song Z; Chen D; Guo M; Liang J; Ding D; Wang W; Yan D
Onco Targets Ther; 2019; 12():9407-9419. PubMed ID: 31819475
[TBL] [Abstract][Full Text] [Related]
13. Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK/ERK pathway.
Sun J; Guo Y; Bie B; Zhu M; Tian H; Tian J; Li J; Yang Y; Ji F; Kong G; Li Z
J Cell Biochem; 2020 Jan; 121(1):443-457. PubMed ID: 31231887
[TBL] [Abstract][Full Text] [Related]
14. A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated by DNMT1 and inhibits migration of glioma cells.
Yao J; Zhou B; Zhang J; Geng P; Liu K; Zhu Y; Zhu W
Tumour Biol; 2014 Aug; 35(8):7935-44. PubMed ID: 24833086
[TBL] [Abstract][Full Text] [Related]
15. Retracted: Knockdown of lncRNA
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9859158. PubMed ID: 37501828
[TBL] [Abstract][Full Text] [Related]
16. HOXD-AS1 facilitates cell migration and invasion as an oncogenic lncRNA by competitively binding to miR-877-3p and upregulating FGF2 in human cervical cancer.
Chen S; Li K
BMC Cancer; 2020 Sep; 20(1):924. PubMed ID: 32977766
[TBL] [Abstract][Full Text] [Related]
17. LncRNA DLGAP1-AS2 modulates glioma development by up-regulating YAP1 expression.
Miao W; Li N; Gu B; Yi G; Su Z; Cheng H
J Biochem; 2020 Apr; 167(4):411-418. PubMed ID: 31899508
[TBL] [Abstract][Full Text] [Related]
18. lncRNA CTBP1-AS2 promotes proliferation and migration of glioma by modulating miR-370-3p-Wnt7a-mediated epithelial-mesenchymal transition.
Li Y; Zong J; Zhao C
Biochem Cell Biol; 2020 Dec; 98(6):661-668. PubMed ID: 33150795
[TBL] [Abstract][Full Text] [Related]
19. Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma.
Wu F; Zhao Z; Chai R; Liu Y; Wang K; Wang Z; Li G; Huang R; Jiang H; Zhang K
Cancer Cell Int; 2018; 18():107. PubMed ID: 30069164
[TBL] [Abstract][Full Text] [Related]
20. LncRNA HOXD-AS1 promotes melanoma cell proliferation and invasion by suppressing RUNX3 expression.
Zhang H; Bai M; Zeng A; Si L; Yu N; Wang X
Am J Cancer Res; 2017; 7(12):2526-2535. PubMed ID: 29312805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
